Invention Grant
- Patent Title: Bupropion as a modulator of drug activity
-
Application No.: US17836560Application Date: 2022-06-09
-
Publication No.: US11628149B2Publication Date: 2023-04-18
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A01N43/46 ; A61K31/55 ; A61K31/137 ; A61K31/485 ; A61K31/135 ; A61K31/15 ; A61K31/381
Abstract:
Disclosed herein are methods of treating neurological or psychiatric diseases or disorders using a combination of bupropion and dextromethorphan. Related compositions and dosage forms are also described.
Public/Granted literature
- US20220323381A1 BUPROPION AS A MODULATOR OF DRUG ACTIVITY Public/Granted day:2022-10-13
Information query
IPC分类:
